Three Texas physician practices settled billing fraud allegations related to neurostimulator devices, according to a June 10 Justice Department statement. Harker Heights-based Ledger Foot & Ankle, ...

A Cleveland-headquartered biotech company has secured $4.5 million in an oversubscribed financing round. Neuronoff Inc., a ...

A study has found that restorative neurostimulation continues to be effective in treating low-back pain caused by multifidus dysfunction after three years. This type of dysfunction occurs when the ...

Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type; Application; and Geography" report has been added ...

Lewes (Del.) Surgery Center has started offering neurostimulator implants for patients living with chronic pain, according to a Cape Gazette report. Lewes Surgery Center, a 5,600-square-foot facility, ...

The US Food and Drug Administration (FDA) has approved Abbott Laboratories’ new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy for the treatment of patients with ...

The pain management devices market size is calculated at USD 8.41 billion in 2025 and is expected to reach around USD 19.1 ...

St. Jude Medical, Inc. STJ today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer™ lead delivery system for neurostimulation therapy. This ...

If you are one of the 50 million Americans suffering from chronic pain, you’ve likely experienced the frustration of trying to treat a problem that has no clear cause. You may even have been told that ...

Chronic pain is pain that persists for longer than expected for the typical illness or injury or for more than 3 to 6 months. The most common causes are low back pain, headache, neck pain and face ...